A Study on Body Fat Distribution and Cardiovascular Risk Factors by Gopinath, G
DISSERTATION ON 
 
A STUDY ON BODY FAT DISRIBUTION 
AND CARDIOVASCULAR RISK FACTORS 
 
 
 
Submitted in partial fulfilment of 
Requirements for 
 
 
M.D. DEGREE BRANCH I GENERAL MEDICINE 
 
Of 
 
THE TAMILNADU DR. M.G.R. MEDICAL UNIVERSITY, 
CHENNAI 
 
 
 
 
 
 
 
 
 
 
 
 
MADRAS MEDICAL COLLEGE 
CHENNAI – 600 003 
 
MARCH 2009 
 
 
 
CERTIFICATE 
 
This is to certify that this dissertation entitled “A STUDY 
ON BODY FAT DISTRIBUTION AND CARDIOVASCULAR 
RISK FACTORS” submitted by Dr. G.GOPINATH   appearing 
for M.D. Branch I General Medicine Degree examination in March 
2009 is a bonafide record of work done by him under my direct 
audience and supervision in partial fulfillment of regulations of the 
Tamil Nadu Dr. M.G.R. Medical University, Chennai. I forward 
this to the Tamil Nadu Dr.M.G.R. Medical University, Chennai, 
Tamil Nadu, and India. 
 
Prof. R.SUKUMAR, M.D 
Professor Of Medicine, 
Institute of Internal Medicine, 
Govt. General Hospital, 
Chennai – 600 003. 
 
 
 
 
 
 
 
Prof. C.RAJENDIRAN, M.D  
Director, 
Institute of Internal Medicine, 
Government General Hospital, 
Chennai - 600003 
Prof.T.P.KALANITI, M.D 
Dean, 
Madras Medical College, 
Government General Hospital, 
Chennai - 600003 
 
DECLARATION 
 
I, Dr.G.Gopinath solemnly declare that I carried out this work on    
“A STUDY ON BODY FAT DISTRIBUTION AND 
CARDIOVASCULAR RISK FACTORS” at Institute of Internal 
Medicine, Government General Hospital and Madras Medical College 
during the period of November, 2007 - November, 2008. I also declare 
this bonafide work or a part of this work was not submitted by me or any 
other Person for any award, degree and diploma to any university, board 
either in India or abroad.   
 
This is submitted to the Tamilnadu Dr.M.G.R. Medical University, 
Chennai in partial fulfillment of the rules and regulation for the M.D. in 
General Medicine Degree examination.  
 
Place:  
Date: 
 
 
 
 
 
Dr. G. GOPINATH, 
M.D. General Medicine  
Postgraduate Student 
Institute of Internal Medicine 
Madras Medical College 
Chennai 
ACKNOWLEDGEMENT 
At the outset I would like to thank our Dean 
Dr.Kalaniti,M.D., for permitting me to carry out this study in our 
hospital. 
I am greatly indebted to my beloved Chief& Head of the 
Department Prof. DrC.RAJENDIRAN, M.D., for his guidance, 
encouragement and support during the study period. 
I am grateful to our chief Prof.Dr.R.SUKUMAR, M.D, professor, 
Department of Medicine, for his guidance and support during this period. 
I express my gratitude to my assistant professors 
Dr.R.S.A.Alexander M.D, Dr.Deepa M.D, for their valuable 
suggestions.  
I am obliged to my guide Prof.Dr.R.ALAGESAN,M.D, D.M. 
Professor and Head,  Department of Cardiology, Dr.Ravishankar .D.M,   
Asst. Professor, Department of Cardiology, of   for their guidance  and  
valuable suggestion. 
 I sincerely thank Prof.Pregna B. Dolia.M.D, Head of the 
Department, Biochemistry, Madras Medical College, for guidance & co-
operation in conducting this study. 
I thank all Professors, Assistant Professors, and Post-
graduates of Department of Cardiology for their valuable support in 
my study.  
I would always remember with extreme sense of thankfulness 
for the co-operation and criticism shown by my Postgraduate 
colleagues. 
I am immensely grateful to the generosity shown by the 
patients who participated in this study. If at all, this study could 
contribute a little to relieve them from their suffering I feel that I 
have repaid a part of my debt. 
 
 
 
 
CONTENTS 
 
 
S.No. CONTENTS Page No. 
1. INTRODUTION 1 
2. AIM OF THE STUDY 4 
3. REVIEW OF LITERATURE 5 
4. MATERIALS & METHODS 55 
5. RESULTS 60 
6. DISCUSSION 71 
7. CONCLUSION 78 
8. APPENDIX  
 BIBLIOGRAPHY  
 PROFORMA  
 MASTER CHART  
 CONSENT FORM  
 ETHICAL COMMITTEE CLEARANCE  
  
1 
 
INTRODUCTION 
 Cardiovascular disease is the leading cause of death in global 
deaths and accounts for 17 million people worldwide. Despite the 
favorable changes in the risk factors, new risk factors have emerged. 
These include abdominal obesity and physical inactivity, both of which 
are considered independent and mediating factors in the development of 
cardiovascular disease. They are also associated with type 2 Diabetes and 
Metabolic syndrome, growing health hazards all over the world and the 
major risk factors for cardiovascular disease.       
 Visceral fat accumulation may underlie the adverse metabolic 
profile associated with obesity. Indeed Waist circumference and Waist 
Hip ratio as indicators of Abdominal obesity have been shown to be 
better than body mass index as an indicator of total adiposity for 
identifying individuals at higher risk of developing atherosclerotic 
diseases. 
 It is plausible that Body mass index may be less sensitive than 
Waist circumference or Waist Hip ratio at capturing the underlying and 
disparate metabolic effects of fat depots.  
 A case control study involving the populations worldwide recently 
reported that Waist Hip ratio was associated with Acute Myocardial 
Infarction independently of, and more strongly than Body Mass index. 
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Furthermore Waist and Hip circumferences have been shown to have 
separate and opposite cross sectional associations with metabolic factors. 
          The Obesity associated increased risk for developing 
cardiovascular disease could be due to the adverse metabolic profile 
associated with increased visceral fat accumulation rather than to 
subcutaneous fat, which comprises >85% of the total body fat.  
           However using more sophisticated instruments, such as MRI, to 
accurately quantify fat in specific depots is impractical for in clinical 
setting. Simple anthropometric measures, which are known to correlate 
with fat distribution, would therefore be preferred.  
           Body mass Index, which is weight/ height², is a measure used to 
define overweight and obesity, but this measure does not provide enough 
information on fat distribution. Alternatively, Waist circumference could 
be measured and is simple enough to use in assessing abdominal obesity 
over time. 
           However Waist Girth when correlated with Hip circumference, a 
measure that showed an independent and seemingly and protective effect 
on Cardiovascular Disease. Without Hip girth taken into account waist 
circumference may underestimate the true cardiovascular risk.  
           Waist Hip ratio may be an alternative measure to use because it is 
strongly predictive of cardiovascular risk in both men and women.  
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          Even lean individuals (BMI<25 kg/m²), an increased Waist Hip 
ratio was associated with higher cardiovascular risk, suggesting that the 
impact of excess visceral fat can be observed even without gaining so 
much weight as to be considered overweight or obese. 
 However, despite the need to reduce excess weight in healthy 
individuals, the role of excess weight reduction in patients with known 
history of cardiovascular disease or diabetes needs further investigation. 
          Skinfold thickness is also used as a measure of adiposity, but 
studies comparing its predictive ability to other measures of adiposity 
have produced inconsistent findings 
           Indians have a low average body-mass index (20–30 kg/m2) and 
low rates of obesity (10–15%) in association with higher prevalence of 
cardiovascular disease and diabetes .Mean waist-hip girth ratios were 
higher and trunk skin folds thicker in south-Asian than in European men 
and women in the absence of corresponding ethnic differences. In 
Indians, wherever they are living, glucose intolerance and insulin 
resistance are associated with obesity and especially with a pattern of 
obesity in which a high proportion of body fat is deposited on the trunk 
and in the abdomen. 
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AIM OF THE STUDY 
1) To investigate the associations of abdominal obesity   and overall 
obesity with the risk of acute coronary events. 
2) To determine the associations of   Waist circumference and Waist 
Hip ratio with the risk of incident cardiovascular events and to 
determine the strength of   association of waist and waist hip ratio 
with cardiovascular risk is different. 
3) To determine which of the five risk factors maintains the strongest 
association with cardiovascular risk. 
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REVIEW OF LITERATURE 
 The leading cause of death in the world is ischemic heart disease, a 
condition characterized by reduced blood supply to the heart that is 
usually due to coronary artery disease. In 2001 alone, some 7.1 million 
deaths were attributed to ischemic heart disease, 80% of which were in 
relatively poor countries6. Medical and public health professionals expect 
that in developing countries, there will be a 137% and 120% increase in 
the disease for males and females, respectively, whereas these predictions 
lie in the 30% to 60% range for developed countries6. 
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RISK FACTORS FOR CORONARY ARTERY DISEASE 
CONVENTIONAL RISK FACTORS 
1. NON MODIFIABLE a) Age 
                                         b) Sex 
                                         c) Family H/o 
                                         d) Genetic 
2.  MODIFIABLE  a) Smoking 
                                  b)  Alcohol intake 
                                  c) Atherogenic Diet 
                                  d) Physical Inactivity 
                                  e) Obesity 
                                  f) Diabetes 
                                  g) Metabolic Syndrome 
                                  h) Hypertension 
                                  i) Dyslipidemias 
                                  j) Mental Stress 
7 
 
 
3. NOVEL RISK FACTORS 
                   a) C-Reactive Protein 
                      b) Homocysteine 
                      c) Fibrinogen and D-Dimer 
     d) Lipoprotein a 
CAD IN INDIA 
 Specific mortality data ideal for making comparisons with other 
countries are not available in India. This is due to inadequate and 
inappropriate death certification, and multiple concurrent causes of death.  
Cardiovascular disease (CVD) is the leading cause of death in India, and 
its contribution to mortality is rising; deaths due to CVD are expected to 
double between 1985 and 2015. 
 Multiple studies have clearly shown that CHD is a significant 
problem in India and coronary risk factors: hypertension, smoking, 
physical inactivity, obesity and truncal obesity, and improper diet leading 
to hypercholesterolemia and hypertriglyceridemia are widespread.                     
          CHD prevalence in urban populations increased from 3.5% in 
1960s to 9.5% in 1990s. In rural areas it increased from 2% in 1970s to 
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4% in 1990s.3-4.  The rates appear to be higher in South India with 
highest in Kerala7. 
          The high rates of CAD in urban India compared to rural, despite 
lower rates of smoking, suggest important roles for nutritional and 
environmental factors. There is a significant increase in BMI in urban 
compared to rural (BMI 24 versus 20 in men, 25 versus 20 in women)7. 
         There is also a higher rate of abdominal obesity among the urban 
population, with urban men having a waist to hip ratio (WHR) of 0.99 
compared to 0.95 among rural men, these increases in BMI and WHR 
result in significant insulin resistance and dyslipidaemia7. Urban-rural 
differences in prevalence of coronary risk factors also provide important 
information regarding risk factors that need prevention. These include 
sedentary life style, hypertension, BMI, WHR / truncal obesity, total and 
LDL Cholesterol/ hypercholesterolemia, triglyceride levels, fasting 
insulin levels/ insulin resistance etc.   
           Based solely on projected demographic trends, it has been 
estimated that deaths attributable to CAD would nearly double, in both 
sexes, in the period 1985-2015 and CAD would emerge, over this period, 
as the single largest contributor to mortality, accounting for nearly a third 
of all deaths, globally7. 
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FACTORS CONTRIBUTING TO THE ACCELERATION OF CAD 
EPIDEMIC IN INDIA 
(i) Demographic transition to an older population, as a result of 
increasing life expectancy  
(ii)  Confluence of both conventional risk factors and non-conventional 
risk factors in Indians. Conventional factors like hypertension, 
diabetes, hypercholesterolemia, smoking etc. owe their origin to 
growing urbanization and western 'acculturation' amongst Indians. 
Non conventional risk factors like hyperinsulinaemia, insulin 
resistance, lipoprotein A etc are determined by genes or other 
'programming' factors and their high prevalence amongst Indians 
probably explain the malignant, precocious nature of CAD that 
typically affects Indians. 
(iii)  Recently indicated relationship between low birth-weight which is 
widely prevalent amongst Indian newborns and enhanced 
susceptibility to CAD in adult life ('Barker hypothesis'). These 
multiplicative effects of conventional and emerging risk factors 
appear to provide a plausible explanation for the excess burden of 
CAD among Indians, many of whom are lean, non-smoking, 
vegetarian, yoga guru and marathon athletes.  
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          The excess risk of CAD in Indians appears to be greater at younger 
ages. When people move from a rural to an urban environment, they 
become sedentary and/or may adopt western lifestyles. Decreased 
physical activity and increased consumption of calories and saturated fat 
result in abdominal obesity, insulin resistance and atherogenic 
dyslipidaemia. These acquired metabolic abnormalities appear to have a 
synergistic effect on the development of CAD in genetically predisposed 
individuals. 
CARDINAL FEATURES OF CORONARY ARTERY DISEASE 
AMONG INDIANS COMPARED TO OTHER POPULATIONS 
•  Higher rates - 2 to 4 fold higher prevalence, incidence, 
hospitalization and mortality. 
•  Greater prematurity 
 -  5 to 10 year earlier onset of first Myocardial infarction (Ml) 
     -  5 to 10 fold higher rate of Ml and death in young «40 years 
of age) 
•  Greater severity 
     -  Three vessel disease common even among young 
premenopausal Women. 
     -  Large Ml with greater muscle damage 
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•  Higher prevalence of glucose intolerance 
     -  Insulin resistance syndrome, diabetes, central obesity 
•  Lower prevalence of conventional risk factors 
    -  Hypertension, obesity, cigarette smoking 
    -  Cholesterol levels: similar to Whites but higher than other 
Asians 
•  Higher prevalence of emerging (thrombogenic) risk factors 
    -  High levels of lipoprotein a, homocysteine, Apoprotein B 
    -  High levels of triglycerides, fibrinogen 
    -  Low levels of HDL 
 -  Small dense LDL 
•  Higher rates of clinical events for a given degree of atherosclerosis 
    -  Double that of Whites 
 -  4 fold higher than Chinese 
    -  Higher proportion of unstable or vulnerable plaques. 
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OBESITY AND CORONARY ARTERY DISEASE 
 Obesity may be defined as an abnormal growth of adipose tissue 
due to an enlargement of fat cell size or increase in the fat cell number or 
both. Although viewed as increased body weight, this need not be the 
case – lean but very muscular individuals may be overweight without 
increased obesity. 
 Obesity is becoming a global epidemic in both children and adults. 
Obesity is an independent risk factor for CVD, and CVD risks have also 
been documented in obese children. Obesity is associated with an 
increased risk of morbidity and mortality as well as reduced life 
expectancy. Health service use and medical costs associated with obesity 
and related diseases have risen dramatically and are expected to continue 
to rise.  
 Besides an altered metabolic profile, a variety of 
adaptations/alterations in cardiac structure and function occur in the 
individual as adipose tissue accumulates in excess amounts, even in the 
absence of co morbidities.  
          Hence, obesity may affect the heart through its influence on known 
risk factors such as dyslipidaemia, hypertension, glucose intolerance, 
inflammatory markers, obstructive sleep apnea/hypoventilation, and the 
prothrombotic state, in addition to as-yet-unrecognized mechanisms. On 
the whole, overweight and obesity predispose to or are associated with 
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numerous cardiac complications such as coronary heart disease, heart 
failure, and sudden death because of their impact on the cardiovascular 
system. 
        However obese individuals differ not only in the amount of excess 
fat that they store but also in the regional distribution of the fat within the 
body. The distribution of fat induced by weight gain affects the risk 
associated with obesity and the kind of disease it results. It is useful 
therefore, to be able to distinguish between those at increased risk as a 
result of abdominal fat distribution or “Android obesity” from those with 
the less serious “Gynoid fat” distribution, in which fat is more evenly and 
peripherally distributed around the body.  
BODY FAT AND METABOLIC SYNDROME 
 The metabolic syndrome is a constellation of metabolic risk factors 
that consist of the following3:  
1. Atherogenic dyslipidaemia [serum elevations of triglycerides           
Apolipoprotein B (apo B), and small low-density lipoprotein (LDL)           
particles plus low high-density lipoprotein (HDL) cholesterol]  
2. Elevated blood pressure  
3. Elevated glucose associated with insulin resistance  
4. Prothrombotic state  
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5. Proinflammatory state  
 National Cholesterol Education Program Adult Treatment Panel III 
report proposed a simple scheme for the routine diagnosis of metabolic 
syndrome. According to this scheme, a diagnosis of metabolic syndrome 
can be made if a person has three of the following five features3:  
1.  Increased waist circumference ( 102 cm in men and 88 cm in 
women)  
2. Elevated triglycerides ( 150 mg/dl)  
3. Reduced HDL cholesterol (<40 mg/dl in men and < 50 mg/dl in 
women)  
4. Elevated blood pressure ( 130/85 mm Hg or on treatment for          
Hypertension)  
5. Elevated glucose ( 100 mg/dl)  
 When the waist circumference is 102 cm or more in men or 88 cm 
or more in women, the term abdominal obesity can be applied3. The 
advantage of measuring waist circumference is that an excess abdominal 
fat is correlated more closely with the presence of metabolic risk factors 
than total body fat.  
 The cut points for defining abdominal obesity are arbitrary. For 
susceptible individuals, lesser accumulations of abdominal fat can 
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precipitate or aggravate metabolic risk factors. This is particularly so in 
certain populations; for example, in Asian populations lower waist 
circumference cut points have been identified to define abdominal 
obesity3. 
           A disputed area in the relation of obesity and metabolic syndrome 
concerns the role of insulin resistance. The interaction between obesity 
and defects in insulin signaling is so complex that it is so far not possible 
to disentangle the two. Obesity causes insulin resistance, whereas insulin 
resistance seemingly exacerbates the adverse effects of obesity. there is 
little doubt that increasing prevalence of overweight/obesity is mainly 
responsible to the rising prevalence of the metabolic syndrome. 
ETIOLOGY 
 The cause of obesity remains elusive. This reflects the fact that 
obesity is heterogeneous group of disorders. At one level the 
pathophysiology of obesity seems simple: a chronic excess of nutrient 
intake relative to the level of energy expenditure.  
 However due to the complexity of the Neuro Endocrine and 
metabolic systems that regulate the energy intake, storage and 
expenditure, it has been difficult to quantitate all the relevant parameters 
over time in human subjects. 
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ROLE OF GENES VERSUS ENVIRONMENT :  Obesity is 
commonly seen in families and the heritability of body weight is similar 
to that of height. Inheritance is usually not Mendelian, however, and it is 
difficult to distinguish the roles of genes and environmental factors. 
Identical twins have similar BMI’s even when reared separately. 
 Whatever the role of genes, it is clear that environment plays a key 
role in Obesity, as evidenced by the fact that famine prevents obesity in 
even the most obese prone individual. Cultural factors are also important 
.These relate to both the availability and the composition of the diet and 
to changes in the level of physical activity. In the industrialized world 
obesity is more common among the poor women, whereas in the 
underdeveloped countries obesity is more common among the wealthier 
women. Although the role of diet composition in obesity continues to 
generate controversy, it appears that high fat diets may promote obesity, 
especially when combined with diets rich in simple carbohydrates.  
SPECIFIC GENES :   A major breakthrough in this field came through 
the identification of the ob gene. The genetically obese mouse (ob/ ob) 
developed severe obesity, insulin resistance and hyperphagia as well as 
efficient metabolism. The product of the ob gene is the peptide LEPTIN1. 
 It Acts primarily through the hypothalamus and decreases the food 
intake and increases the energy expenditure. 
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PATHOGENESIS 
 The adipose tissue is not simply a passive storehouse for fat but an 
endocrine organ that is capable of synthesizing and releasing into the 
bloodstream an important variety of peptides and nonpeptide compounds 
that may play a role in cardiovascular homeostasis. They are2:- 
1.  Leptin      
2. Tumor necrosis factor-  (TNF- ) 
3.  Interleukin-6 (IL-6)                            
4. Plasminogen activator inhibitor-1 
5. Resistin                                              
6. Lipoprotein lipase 
7.  Acylation stimulating protein             
8. Cholesteryl-ester transfer protein  
9. Retinal binding protein                       
10. Angiotensinogen 
11. Estrogens (through P450 Aromatase activity)                  
12. Adiponectin  
13. Insulin-like growth factor-I (IGF-1)               
14. Insulin-binding protein 3 (IGFBP3)  
15.  Monobutyrin.                                     
16. Non Esterified Fatty Acids (NEFA) 
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ROLE OF NEFA’S  
 Obese persons release increased amounts of NEFAs into the 
circulation. NEFAs are derived by lipolysis of adipose tissue 
triglycerides. The greater the amount of fat in adipose tissue, the more the 
amounts of NEFAs released will be. This greater release of NEFAs 
proceeds despite the higher insulin levels that are present in obese 
persons. Even though high insulin levels suppress adipose tissue lipolysis, 
they cannot reduce NEFA release to normal in obesity. NEFAs are the 
primary source of nutrient energy in the fasting state3. Excessive influx of 
NEFAs into muscle leads to insulin resistance3. The mechanisms wherein 
increased fatty acids in muscle cause insulin resistance have not been 
fully elucidated. Recent research suggests that muscle levels of 
diacylglycerol are raised, which stimulates the serine phosphorylation of 
the insulin receptors and thereby inhibits normal insulin signaling. The 
19 
 
resulting insulin resistance in muscle predisposes to hyperglycemia; the 
latter becomes clinically manifest in those persons to acquire a defect in 
insulin secretory capacity.  
 Influx of excess NEFAs into the liver increases the triglyceride 
content of the liver (fatty liver)3. Fat accumulation in the liver seemingly 
produces insulin resistance as it does in muscle. Reduction in insulin 
action in liver allows for enhanced glyconeogenesis and increased hepatic 
glucose output; this will accentuate hyperglycemia in those patients who 
have reduced insulin secretory capacity3.  
OTHER FACTORS :  Adiponectin increases insulin sensitivity and 
lipid oxidation and has vascular protective effects. Resistin and RBP-4 
increases insulin resistance. IL-6, TNF-α, other cytokines is increased in 
obese individuals and causes insulin resistance in adipocytes. Abdominal 
adipose tissue is more active in PAI-1 synthesis than lower-body adipose 
tissue3. The resulting high PAI-1 level in obese persons together with the 
high plasma fibrinogen observed in such persons contributes to a 
prothrombotic state.  
ATHEROGENIC DYSLIPIDEMIA :  Increased fat in the liver also 
promotes development of atherogenic dyslipidaemia. It provides a 
stimulus for increased formation and secretion of very LDL (VLDL) 
particles. The result is higher serum levels of triglyceride, apo B, and 
small LDL particles. High serum triglycerides reduce HDL-cholesterol 
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concentrations through exchange of VLDL triglycerides with HDL 
cholesterol esters. HDL-cholesterol lowering is accentuated by an 
increase in synthesis of hepatic lipase that occurs in people with obesity-
induced fatty liver; lipase degrades HDL particles, converting large HDL 
into small HDL. 
 A theory widely held is that smaller LDL particles are more 
atherogenic than larger LDLs3. Smaller LDLs may filter more readily into 
the arterial wall. They further may be more prone to atherogenic 
modification. Even so, not all investigations are convinced that small 
LDL particles are unusually atherogenic, compared with other apo B-
containing lipoproteins.  
 Nonetheless, when small LDLs are present, the total numbers of 
lipoprotein particles in the LDL fraction usually are increased. 
CARDIOVASCULAR IMPACT OF INCREASED ADIPOSE 
TISSUE MASS   
 Obesity produces an increment in total blood volume and cardiac 
output that is caused in part by the increased metabolic demand induced 
by excess body weight. Thus, at any given level of activity, the cardiac 
workload is greater for obese subjects. Obese subjects have higher cardiac 
output and a lower total peripheral resistance than do lean individuals. 
The increased cardiac output is attributable mostly to increased stroke 
volume because heart rate increases little if at all. Also, in obesity, the 
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Frank-Starling curve is shifted to the left because of incremental increases 
in left ventricular filling pressure and volume, which over time may 
produce chamber dilation. Ventricular chamber dilation may then lead to 
increased wall stress, which predisposes to an increase in myocardial 
mass and ultimately to left ventricular hypertrophy, characteristically of 
the eccentric type. 
          Eccentric LVH which is commonly present in morbidly obese 
patients (BMI 40 kg/m2), is often associated with left ventricular diastolic 
dysfunction2. Moreover, as with left ventricular mass, longer durations of 
obesity are associated with poorer left ventricular systolic function and 
greater impairment of left ventricular diastolic function.  
            Because of the presence of nonspecific symptoms, the evaluation 
of the presence of left ventricular diastolic dysfunction is clinically 
important in obese subjects. Age and cardiac hypertrophy of the 
concentric or, more commonly, the eccentric type predispose to left 
ventricular systolic dysfunction. 
          In humans and most animal models, the development of obesity 
leads not only to increased fat depots in classic adipose tissue locations 
but also to significant lipid deposits in other organs. With fat gain, lipid 
deposition can impair tissue and organ function in 2 possible ways2: 
 1. The size of fat pads around key organs may increase substantially, 
modifying organ function either by simple physical compression or 
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because periorgan fat cells may secrete various locally acting 
molecules, and  
2.  Lipid accumulation can occur in nonadipose cells and may lead to 
cell dysfunction or cell death, a phenomenon known as lipotoxicity. 
CLINICAL AND LABORATORY ASSESSMENT OF OBESE 
INDIVIDUALS 
 The methods to assess body composition are numerous and also 
difficult to organize systematically. The most accurate methods in 
assessing body fat mass include underwater body density measurement, 
body fat content  estimation by dual energy X-ray absorptiometer 
(DEXA), magnetic resonance imaging (MRI), and computerized 
tomography (CT). These methods are time-consuming and require 
expensive equipment and thus are not feasible for large epidemiological 
studies. In epidemiological studies overweight, overall obesity, and 
abdominal obesity are typically measured by using ratios of body weight 
and height or body circumferences, such as Body Mass Index (BMI), 
waist circumference, and Waist Hip Ratio (WHR). In epidemiological 
studies overweight, overall obesity, and abdominal obesity are typically 
measured by using ratios of body weight and height or body 
circumferences, such as BMI, waist circumference, and WHR. BMI, 
WHR, and waist circumference are continuous variables and when used 
to define overweight or obesity, their cut-off points are arbitrary. 
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BODY MASS INDEX (BMI)* 
 The BMI of a person is the number obtained by dividing his weight 
(in kilograms) by the square of his height (in meters): 
   (Weight in Kilograms) 
 BMI = ------------------------------------ 
   (Height in Meters)2 
   
    
 BMI is highly correlated with body weight and is a surrogate 
measure of total body fat content but is also affected by muscle mass. 
           World Health Organization (WHO, 2000, p. 8-9) and by the Expert 
Panel on the Identification, Evaluation, and Treatment of Overweight and 
Obesity in Adults (1998) are based on an increased risk of morbidity and 
mortality in different populations8.   
 BMI <18.5 kg/m2 is defined as underweight 
            18.5-24.9 kg/m2 as normal weight 
            25.0-29.9 kg/m2 as overweight 
            And > 30 kg/m2 is considered as obesity.  
Obesity can be further stratified into  
            Moderate obesity (BMI 30-34.9 kg/m2)  
            Severe obesity (35-39.9 kg/m2) 
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            Very severe obesity (≥40 kg/m2) 
 In adult Asians, a person is considered underweight if his BMI is 
<18.5 kg/m²; he is considered normal if his BMI is 18.5 to 22.9 kg/m²; he 
is considered overweight if his BMI is > 23 kg/m²; he is considered obese 
if his BMI is > 25 kg/m²(9). 
WAIST CIRCUMFERENCE (WC) * 
 Adipose tissue (fat) distributed centrally within the abdomen and 
among the viscera is also a predictor of cardiovascular, Cerebrovascular, 
and metabolic (diabetes & hyperlipidemia) diseases. The cut-off points of 
waist circumference and WHR are sex and population-specific. 
 The World Health Organization has recommended the use of a cut-
off point for waist circumference of 88 cm in women and 102 cm in men 
and for WHR of 0.85 in women and 1.0 in men to define an increased 
health risk (World Health Organization 2000, p. 9-11). The same cut-off 
points for waist circumference have been recommended by the Expert 
Panel on the Identification, Evaluation, and Treatment of Overweight and 
Obesity in Adults (1998) and the National Cholesterol Education 
Program (Ford et al. 2002). 
SEX IDEAL INCREASED RISK GREATER RISK 
M ‹94 cm 94 – 101cm ›102 cm 
F ‹80 cm 80 – 87 cm ›88 cm 
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(Ref: Han et al , BMJ 1995 311:1401 – 5) 
 Waist circumference appears particularly useful in the clinical 
setting, where both BMI and waist girth can be easily measured and 
followed in time (Despres et al. 2001)8. Waist circumference, however, is 
to some extent correlated with body height, and thus tall persons may 
falsely be categorized into the abdominally obese group. 
           In Asian Indians Cutoff values for Waist circumference were 85 
and 80 cm for men and women9. 
 Measure the waist circumference as recommended by the World 
Health Organization11: 
1. The subject should be lightly dressed; measurement should not be 
made through thick or bulky clothing. 
2. Position the subject upright with feet 25 – 30 cm apart and weight 
evenly distributed. 
3. Sit yourself by the subject comfortable on a chair. 
4. Fit a tape measure snugly around the abdominal girth without 
compressing soft tissue and measure the waist circumference to the 
nearest 0.1 cm in a horizontal plane midway between the inferior 
costal margin and the iliac crest. 
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WAIST-HIP RATIO (WHR) 
 The Waist-Hip Ratio of a person is obtained by dividing his “Waist    
circumference” by his “Hip circumference”: 
   (Waist Circumference in cm) 
 WHR = ---------------------------------------------- 
    (Hip circumference in cm) 
   
         Hip circumference can be measured around the pelvis at the point of 
maximal protrusion of the buttocks. 
         A WHR > 1.0 in European men or 0.85 in European women is 
associated with increased risk of ischemic heart disease, stroke, and 
diabetes8.  
 In Asian Indians Cutoff values for WHRs were 0.88 and 0.81, 
respectively for males and females respectively ((Journal of Association 
of Physicians of India 2007, vol. 55)9. 
 WHR is considered to be a ratio between fat stored centrally inside 
the abdomen (waist circumference) and fat stored peripherally (hip 
circumference).  Waist girth and WHR are better measures of intra-
abdominal fat and probably also of total fat than BMI when validated 
against computer tomography or magnetic resonance imaging 8. 
 Although the current recommendation seems to favor the use of 
waist circumference in assessing abdominal obesity, WHR remains a 
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suitable method for research purposes (World Health Organization 2000, 
p.10)8. 
        WHR has been criticized due to its inability to classify obesity in 
follow-up studies, particularly in women, if the subjects gain weight in 
the waist and hip areas simultaneously (Despres et al. 2001)8. 
Furthermore, it is difficult to interpret whether a large WHR is 
attributable to a large waist girth or to narrow hips. Previous studies 
suggest that both narrow waist and large hips may protect against CVD 
and for this reason, it is recommended that waist and hip girths should be 
measured (Lissner et al. 2001; Seidell et al. 2001b)8. 
          Both BMI and WHR are confounded by sex, age, and ethnic 
background. Also the distribution of overweight and obesity is different 
across populations (World Health Organization 2000)8.  
          In general, men tend to have higher amounts of visceral adipose 
tissue than women, particularly pre-menopausal women (Lemieux et al. 
1993), older persons have larger waist circumferences than younger ones 
(Molarius and Seidell 1998)8, and morbidity risks at the same level of 
overweight vary across different ethnic populations (Seidell et al. 
2001a)8. Therefore, instead of globally accepted cut-off points for 
obesity, there need to be age, sex, and race-specific categories for 
overweight and obesity. 
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          Nevertheless, it is important to understand that BMI, waist 
circumference, and WHR estimate fat mass at different locations, reflect 
different etiological perspectives, and thus do not assess identical 
phenomena. 
SKIN FOLD MEASUREMENT 
           An increase in weight in relation to height does not always mean 
fatness or obesity if the increase in weight is due to muscle mass as in 
body-builders. Degree of fatness (adiposity) correlates better with the 
increased risks of diseases. Skin fold thickness is often used to measure 
this adiposity. 
          Measurement of skin fold thickness requires special calipers. 
Various areas of the body have been suggested as suitable for measuring 
skin fold thickness, including back of the arm over the triceps, below the 
scapulae at the back, and at the supra-iliac region of the anterior 
abdominal wall. 
           A Skinfold Caliper is designed specifically for simple accurate 
measurement of subcutaneous tissue. Either a 7 or 3 site skinfold may be 
assessed.  
7 Site skinfold 
• chest  
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• triceps  
• subscapular  
• axilla  
• suprailiac  
• abdomen  
• thigh  
3 Site skinfold (Men) 
• chest  
• abdomen  
• thigh  
3 Site Skinfold (Women) 
• tricep  
• suprailiac  
• thigh  
BICEPS :  The anterior surface of the biceps midway between the 
anterior auxiliary fold and the antecubital fossa11. 
TRICEPS :  A Vertical fold on the posterior midline of the upper arm, 
over the triceps muscle, halfway between the acromion process (bony 
process on top of the shoulder) and olecranon process (bony process on 
elbow). The elbow should be extended and the arm relaxed11. 
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SUBSCAPULAR :  The fold is taken on the diagonal line coming from 
the vertebral border to between 1 and 2 cm from the inferior angle of the 
scapulae. (A diagonal fold about 1 to 2 cm below the point of the 
shoulder blade and 1 - 2 cm toward the arm)11. 
SUPRAILIAC :  A diagonal fold above the crest of the ilium at the spot 
where an imaginary line would come down from the anterior auxiliary 
line just above the hip bone and 2 - 3 cm forward11. 
CHEST (JUXTA-NIPPLES) : A diagonal fold taken one half of the 
distance between the anterior auxiliary line and the nipple. (The anterior 
auxiliary line is the crease where the top of the arm, when hanging down, 
meets the chest.)11 
ABDOMINAL : The vertical fold taken at the lateral distance of 
approximately 2 cm from the umbilicus (2cm to the side of the 
umbilicus)11. 
THIGH : A vertical fold on the anterior aspect of the thigh, midway 
between the hip and knee joints (on the front of the thigh halfway 
between the hip joint, where the leg bends when the knee is lifted, and the 
middle of the knee cap). The leg should be straight and relaxed)11. 
 If each test is performed correctly according to the recommended 
guidelines, there is a +/- 3% error. Validity 7 site skinfold (r = .90), 3 site 
skinfold (r = .89)15. 
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Advantages 
• Easy to use once skill has been mastered  
• Does not require much time  
• Noninvasive method  
Disadvantages 
• Technical sources of error  
• Mostly concerned with subcutaneous fat (under the skin)  
• May not be an ideal measurement for those who are obese and very  
 lean  
           A major source of error in measuring skinfold fat is variation in 
the placement of the skinfold caliper at the selected anatomical site. The 
subcutaneous fat variability can be a problem when measurements at one 
or several sites are used to represent overall body fat composition. These 
measurements overall are substantially less reproducible than most other 
anthropometric measurements. Several investigations have suggested that 
truncal obesity may have a greater correlation to carbohydrate and lipid 
metabolism disorders and hypertension compared to peripheral obesity. 
           Because of the increased errors involved, it is usually not 
appropriate to convert skinfold measure to percentage body fat (%BF). It 
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is best to use the sum of several sites to monitor and compare body fat 
measures15. 
           Although measurement errors in skinfold thickness tended to 
increase with increasing obesity levels, the influence was smaller for the 
abdominal and suprailiac skinfolds compared with other sites. 
BIOELECTRICAL IMPEDANCE  
 Bioelectrical impedance measures the body’s electrical impedance 
(resistance) to a small electric current. This impedance measurement can 
be analyzed to provide an estimate of the adiposity (amount of fat tissue 
in the body) of a person. 
 It is recommended the following guidelines be followed12:  
• Abstain from eating and drinking within 4 hours of the test  
• Avoid exercising within 12 hours of the test  
• Void (urinate) completely prior to testing  
• Do not drink alcohol within 48 hours of the test  
• Avoid taking diuretics prior to testing   
 However, accuracy is dependant upon several client-based 
variables. Wrong interpretation of adiposity through measurement of 
bioelectrical impedance can result due to the presence of fluid in the 
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limbs (edema), fluid in the abdominal cavity (ascites), a full urinary 
bladder, or excessive sweating. 
Advantages 
• Requires little or no technical knowledge of the operator or the    
 client  
• Testing itself takes less than a minute  
• The unit can be easily transported from place to place  
• Requires only an electrical outlet and the machine itself  
Disadvantages  
• This method has a higher standard error range than most people  
 desire  
• Tends to consistently overestimate lean people and underestimate 
obese people  
• The accuracy BIA does have is very dependant on multiple 
variables which may be hard to control for some people  
          There is doubt whether bioelectrical impedance measurement 
offers any advantage over BMI, WC, or WHR measurement. Its need of 
specialized equipment is another disadvantage. 
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DUAL ENERGY X-RAY ABSORPTIOMETRY (DEXA) 
 It is based on the three component model of body composition. 
DEXA uses two X-ray energies to measure body fat, muscle, and bone 
mineral.  
 When having the scan done, one must lay still in the supine 
position on what looks like an x-ray table. It takes approximately twelve 
minutes for the computer software to produce an image of the tissues. 
The results may be viewed as whole body estimates of body fat, muscle, 
and bone mineral as well as regional body estimates12. 
Advantages  
• Radiation exposure is low  
• DEXA is quick  
• One does not have to wear a bathing suit or skimpy clothing  
• There is no special preparation on the part of the participant  
Disadvantages  
DEXA is costly 
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DEXA takes bone mineral content into consideration when 
estimating body fat and muscle; therefore it is considered to be more 
accurate and valid than a two component model of body composition 
such as underwater weighing12. 
MAGNETIC RESONANCE IMAGING:- 
          Cross-sectional abdominal images obtained with MRI, as shown in 
Figure, allow for separation of the subcutaneous adipose tissue (SAT) 
from the visceral adipose tissue (VAT) compartment. Several studies 
have examined the relationship between the VAT and SAT compartments 
for adults and children. Equations have been developed for the calculation 
of the VAT or SAT area based on anthropometric measurements, e.g., 
waist circumference or skinfolds. Although these equations may predict 
the average VAT for a population, they have limited accuracy for the 
individual. A significant advantage of MRI for body composition studies 
is its potential for monitoring changes in the VAT and SAT 
compartments separately, information which is presently not available 
with any alternate in vivo techniques except for CT. The MRI-derived 
estimates for abdominal SAT and VAT will serve as a reference measure 
of adiposity for testing the efficacy of future therapies for obesity12.  
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Fig : Distribution of total body fat and visceral fat in an adult, nonobese 
male obtained using magnetic resonance imaging. 
 
COMPUTED TOMOGRAPHY 
 This basic anatomical image is similar to that obtained using MRI, 
except it contains additional information for the tissue's true density at 
each pixel. This information coupled with the anatomical location of the 
pixel within the image can be used to identify it as adipose, muscle, skin, 
viscera, or bone tissue. Reconstruction of total body mass and separate 
organ masses based on scans along the length of the body at 10-cm 
intervals has been shown to have excellent accuracy (<1% error) and 
precision (<1%). These reconstructed CT images, and those for MRI, can 
be assigned to level 4 or tissue systems level of the multicompartment 
model. The CT images can also be used to separate the total adipose 
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tissue mass into its subcutaneous and visceral components, or the lean 
tissues into skeletal muscle and visceral or organ mass12. 
NEAR INFRARED INTERACTANCE (NIR) 
 This method of assessing body fat is based on the principles of 
light absorption, reflectance, and near infrared spectroscopy. To estimate 
body composition, a computerized spectrophotometer that has a scan and 
probe are used. The probe is placed onto a selected body site such as the 
biceps; it emits an infrared light which passes through both fat and 
muscle and is reflected back to the probe. Subject data such as height, 
weight, sex, age, frame size and activity level are taken into 
consideration. Density measurements are obtained and incorporated into 
the manufacturer’s prediction equations. A digital read out including 
percentage body fat and lean tissue are displayed. 
 This method of assessing body fat is not the most accurate. In a 
study by *Mclean et al (1992), it was found that skinfolds more 
accurately predicted body fat than NIR when underwater weighing was 
used as the criterion measure. In their study, NIR underestimated body fat 
by more than 4% in subjects greater than 30% fat and overestimated body 
fat by 4% in subjects less than 8% fat11. 
Advantages  
• Safe  
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• Non-invasive  
• Fast  
• Convenient.  
Disadvantages 
• Not one of the most accurate techniques used to assess body fat 
composition.  
UNDERWATER WEIGHING (HYDROSTATIC WEIGHING) 
 This method uses Archimedes principle which states that when a 
body is submerged in water, there is a buoyant counter force equal to the 
weight of the water which is displaced. 
 Because bone and muscle are denser than water, a person with a 
larger percentage of fat free mass will weigh more in the water and have a 
lower percent body fat. Conversely, fat floats. Therefore, a large amount 
of fat mass will make the body lighter in the water and have a higher 
percent body fat. If each test is performed correctly according to the 
recommended guidelines, there is a +/- 1.5% error. 
Advantages  
• This method is currently considered the "gold standard" in percent 
body fat measurement  
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• Repeat measures usually prove consistent, and can be used to chart 
progress  
Disadvantages:  
• This method usually requires a lot of equipment and space  
• Testing is time consuming and involved  
• Requires in-depth knowledge to administer the tests and compute 
the calculations  
• Being submerged under water may be difficult and produce anxiety 
for some  
TREATMENT:- 
DIAGNOSTIC APPROACH:- 
• Calculate body mass index and measure waist circumference. 
•  Determine degree and rate of acquisition of obesity. 
•  Exclude identifiable causes of obesity. 
•  Assess co morbid conditions, presence of cardiovascular risk 
factors, and absolute risk status. 
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• Conditions that indicate high absolute risk for obesity-related 
disorders 
• Established coronary artery disease 
• Other atherosclerotic disease 
• Type 2 diabetes mellitus 
• Sleep apnea 
• ≥3 of the following indicate high absolute risk for obesity related 
disorders. 
• Hypertension 
• Cigarette smoking 
• High low-density lipoprotein cholesterol level (>160 mg/dL) 
• Low high-density lipoprotein cholesterol level (<35 mg/dL)  
• Impaired fasting glucose  
• Family history of early coronary artery disease 
• Age > 45 in men and age > 55 in women. 
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TREATMENT APPROACH  
 Patients who meet the following criteria should be considered for 
treatment.  
• BMI >30 mg/kg2  
• BMI 25–29.9 mg/kg2 and presence of ≥2 risk factors  
• BMI 25–29.9 mg/kg2 and waist circumference >102 cm (40 in) in 
men or >88 cm (35 in) in women  
• Combined therapy with a low-calorie diet, increased physical 
activity, and behavior therapy provide the most successful 
intervention for weight loss and weight maintenance.  
• All patients should be counseled on lifestyle and behavioral 
modifications (appropriate diet and physical activity), and weight 
loss goals should be individualized.  
• Treatment goals should be guided by the health risks of obesity in 
any given person.  
42 
 
Specific Treatments  
Behavior modification  
• The principles of behavior modification provide the underpinnings 
for many current programs of weight reduction.  
• Goal of behavior modification is to modify maladaptive behaviors, 
including eating habits and physical activity.  
• Patient is asked to monitor and record the circumstances related to 
eating and physical activity.  
Dietary therapy  
• Reduced caloric intake is the cornerstone of obesity treatment.  
• There is no scientific evidence to validate the utility of specific 
"fad diets."  
• General facts relevant to food intake and weight loss  
• Deficit of 7,500 kcal will produce a weight loss of ~1 kg.  
• Consuming 100 kcal/d less for 1 year should cause a 5-kg weight 
loss.  
• Consuming 1,000 kcal/d less should cause a loss of ~1 kg per 
week.  
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• Rate of weight loss on a given caloric intake is related to rate of 
energy expenditure.  
• Obese persons have a higher metabolic rate than lean persons.  
• Men have a higher metabolic rate than women (due to their greater 
lean body mass); thus, the rate of weight loss is greater among 
more obese and among men.  
• With chronic caloric restriction, the metabolic rate decreases.  
• With total starvation or diets restricted to < 600 kcal/d, initial 
weight loss over the first week results predominantly from 
natriuresis and the loss of fluids.  
Very-low-calorie diets (400–600 kcal/d)  
 It may be appropriate for short-term treatment of obesity in 
selected patients.  
• Use should be restricted to patients >130% of ideal body weight.  
• Most commonly used for 1–2 months to initiate more rapid weight 
loss, improve co morbid conditions, and provide patients with 
positive feedback  
• Safe in selected patients under medical supervision  
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Daily diet composition  
• 45–70 g high-quality protein  
• 30–50 g carbohydrate  
• 2 g fat  
• Supplements of vitamins, minerals, and trace elements  
Advantages  
• Greater rate of weight loss compared with less restrictive diets  
• Possible beneficial effect of hunger suppression from production of 
ketones  
• Blood pressure and blood glucose, cholesterol, and triglyceride 
levels decrease.  
• Pulmonary function and exercise tolerance improve.  
• Sleep apnea may improve within a few weeks.  
Complications  
 Minor  
• Fatigue, constipation or diarrhea  
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• Dry skin  
• Hair loss  
• Menstrual irregularities  
• Orthostatic dizziness  
• Difficulty concentrating 
• Cholelithiasis and pancreatitis may occur when a very-low-calorie 
diet is  interrupted by binge eating.  
• Gallstones develop in up to 25% of patients on a very-low-calorie 
diet.  
• Close supervision is required in patients with diabetes who are 
receiving insulin or oral agents.  
Contraindications  
• Pregnancy  
• Cancer  
• Recent myocardial infarction  
• Cerebrovascular disease  
• Hepatic disease  
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• Untreated psychiatric disease  
• Patients may benefit from counseling offered in a stable group 
setting for extended periods of time, including after weight loss. 
 Low-calorie diets (>800 kcal/d)  
• Are applicable to most patients and have fewer restrictions than 
very-low-calorie diets.  
• Considerable controversy surrounds the question of what 
constitutes the best diet composition for promoting weight loss.  
Low-fat diets  
• Commonly recommended, but benefits to obesity reduction from 
very-low-fat diets are modest at best  
• Health effects aside from weight reduction may be important.  
• Large amounts of simple carbohydrates are substituted for fats but 
may actually promote obesity.  
• Diets rich in fruits, vegetables, whole grains, and other low–
glycemic index carbohydrates may promote weight loss and are 
preferable to low-fat diets.  
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• Diets with protein replacement of simple carbohydrates aim to 
minimize insulin production.  
• Efficacy of this strategy, aside from overall calorie reduction, is 
unknown.  
Very-low-carbohydrate "Atkins" style diets  
• More effective for short-term weight loss when compared to 
standard caloric restriction, but have not been shown to be more 
effective in maintaining weight loss  
• Consequences of maintaining a lower body weight at the expense 
of consuming more saturated fat are unknown.  
• Diet therapy education is important to prevent weight regain.  
• Patients should be counseled on the caloric content of specific 
portions to promote weight loss and maintenance.  
Exercise  
• Physical activity is an important component of the overall approach 
to weight reduction and maintenance.  
• The effect of an exercise regimen as a sole therapy for obesity is 
not established, but exercise is a valuable means to sustain diet 
therapy. 
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• Additional benefits  
o Improves cardiovascular tone and reduce blood pressure, 
independent of weight loss  
o Helps reduce appetite  
o Increases the likelihood of weight maintenance once targets are 
achieved  
o Reduces intra-abdominal fat  
o Reduces risk of glucose intolerance  
• Many obese persons have not exercised on a regular basis and may 
have cardiovascular risk factors.  
o Exercise should be introduced gradually under medical 
supervision, especially in the most obese patients.  
• Minimal physical activity recommendations  
o Adults should engage in moderate-intensity physical activities for 
≥ 30 minutes on ≥ 5 days of the week or  
o Adults should engage in vigorous-intensity physical activity ≥ 3 
days per week for ≥ 20 minutes per occasion.  
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Pharmacotherapy  
• May be considered as adjunctive therapy in patients with a BMI 
≥30 kg/m
2 
or ≥27 kg/m
2 
with other risk factors or diseases who fail 
to achieve weight loss goals through non pharmacologic 
approaches  
• Limitations  
• Medication-induced weight loss is not a cure despite modest short-
term benefits from several agents.  
• Safety and efficacy of weight loss agents beyond 2 years has not 
been established.  
• Rebound weight gain after the cessation of drug use is common.  
• Most agents are associated with substantial side effects, and some 
have potential for abuse.  
• PHENTERMINE :  approved for short-term use (<12 weeks).  
o Mechanism of action: increases the release of nor epinephrine and 
dopamine from nerve terminals and inhibits their reuptake  
o Dosing: 15 mg–30 mg/d  
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o Efficacy: modest (10 versus 4.4 kg of weight loss over 24 weeks in 
a well-controlled study)  
o Side effects (numerous): insomnia, dry mouth, constipation, 
palpitations, hypertension  
• SIBUTRAMINE: approved for long-term use.  
o Mechanism of action: central reuptake inhibitor of both nor 
epinephrine and serotonin  
o Dosing: 10 mg/d  
o Efficacy: Once-daily dose over 24 weeks produced a 7% weight 
loss and decreased cholesterol and triglyceride levels in a double-
blind, placebo-controlled trial.  
o Adverse effects: increases pulse by an average of 4–5 beats/min and 
blood pressure by 1–3 mmHg  
• ORLISTAT :  approved for long-term use.  
o Mechanism of action: inhibitor of pancreatic lipase with no 
systemic availability; causes modest weight loss due to drug-
induced fat malabsorption  
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o Dosing: 120 mg 3 times daily, before meals, taken with a 
multivitamin  
o Efficacy: 2-year randomized, double-blind trial revealed modest 
weight loss (8.7 kg for 120 mg of orlistat versus 5.8 kg from diet 
alone) during first year and better maintenance of weight loss in 
second year compared with the placebo group (3.2 kg regained vs. 
5.6 kg regained for placebo)  
o Adverse effects  
o GI side effects include oily stools, flatulence, and fecal urgency; 
these usually diminish as patients limit fat intake to avoid 
symptoms.  
o Absorption of fat-soluble vitamins is decreased.  
• METFORMIN tends to decrease body weight in patients with 
obesity and type 2 diabetes mellitus.  
• RECOMBINANT LEPTIN  
o  Is highly effective in rare cases of Leptin deficiency caused by 
mutations of the Leptin gene.  
o Regulates hunger and induces loss of fat mass while preserving lean 
body mass.  
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o Response to Leptin is limited or absent in common obesity, which is 
associated with hyperleptinemia and Leptin resistance.  
Surgery  
• Bariatric surgery should be considered for patients meeting the 
following criteria.  
o BMI >35 kg/m2 with an associated co morbid condition or BMI 
>40 kg/m
2 
 
o Repeated failure of other therapeutic approaches  
o At eligible weight for 3–5 years  
o Capable of tolerating surgery  
o Absence of alcoholism, other addictions, or major psychopathology  
o Prior clearance by a psychiatrist  
• Vertical-banded gastroplasty  
o Purely restrictive procedure  
• Roux-en-Y gastric bypass  
o Combines restriction with slight malabsorption  
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o May also reduce appetite via suppression of gastric hormone 
ghrelin  
o Most often performed via laparotomy, but may be performed 
laparoscopically  
o May be associated with risk of islet hyperplasia and hypoglycemia  
• Laparoscopic adjustable gastric banding 
Potential benefits  
o Significant, sustained weight loss (10–159 kg over 1–5 years)  
o Improvements in hypertension, diabetes, sleep apnea, congestive 
heart failure, angina, hyperlipidemia, and venous disease  
Short-term complications  
o Pulmonary embolus  
o Anastomotic leak  
o Bleeding  
o Wound infection  
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Long-term complications depend on the specific surgical procedure 
but include:  
o Dumping syndrome  
o Stomal stenosis  
o Marginal ulcers  
o Hernias  
o Lifelong medical monitoring after surgery is necessary.  
o Lifelong supplementation with vitamin B12, iron, folate, and 
calcium is recommended.   
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MATERIALS AND METHODS 
PLACE OF STUDY :  This is a standardized case control study 
conducted in the Government General Hospital and Madras Medical 
College, Chennai from November 2007 to November 2008. 
INCLUSION CRITERIA   
1)  Consecutive cases of newly diagnosed Myocardial Infarction. 
2)  With/ without risk factors for IHD. 
EXCLUSION CRITERIA 
1)  Old cases of Myocardial infarction/ unstable angina/ chronic stable 
angina.  
2)  Cardiogenic shock 
3)  Major Chronic diseases 
4)  Age > 60 yrs due to non reliability of skin fold thickness. 
STUDY POPULATION 
 A total of 98 cases (49 Cases and 49 Controls) were selected. 
Newly diagnosed consecutive cases of myocardial infarction admitted to 
the department to the department of cardiology were enrolled into the 
study after obtaining consent.  
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 These patients were subjected to anthropometric measurements 
namely waist hip ratio, weight height, skin fold thickness and S.Lipid 
profile was done. Controls were selected from the outpatient clinic of 
Institute of Internal Medicine. Controls were matched for age, sex, risk 
factors. They were also subjected to anthropometric measurements and 
S.Lipid profile. 
STUDY DESIGN 
 Standardised Case Control Study, to assess whether markers of 
obesity especially waist hip ratio would be stronger indicators of 
myocardial infarction than body mass index, the conventional measure.   
METHODOLOGY 
1. BODY MASS INDEX 
 Weight was measured in KG’s. The weighing apparatus was 
calibrated at the beginning of each and at the end of each stand. Weight 
was determined on a balance scale in light clothing to an accuracy of 
100g. 
 Height was measured using Stadiometer in cm. Height was 
measured without shoes by a measuring tape against a wall to an accuracy 
of 0.1 cm with patient looking straight ahead, shoulders relaxed, arms by 
sides legs straight and knees together. Shoulder blades, buttocks and heels 
touching the measurement surface. 
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 BMI was calculated using the following formula 
 BMI   =      Weight (in Kg) / Height in metre2 
 The study population was divided into two groups < 25 and ≥25 
(World Health Organization 2000, p. 9-11). 
2. WAIST HIP RATIO 
 Waist circumference was measured over unclothed abdomen at the 
midpoint between the iliac crest and the lowest rib.  It was calculated as 
an average of one measurement taken after inspiration and one taken after 
expiration. 
 Hip circumference was measured over light clothing at the level of 
the Tronchanteric major or widest diameter around buttocks.  
         All anthropometric measurements were carried out once.  
         WHR was calculated as waist divided by hip, and was used in the 
analyses either as a continuous variable or divided into sex-specific 
thirds. 
3. SKIN FOLD THICKNESS 
 All the skin folds were taken with Vernier calipers. The 
measurements are taken on the right side of the body. The fold of skin 
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and underlying subcutaneous adipose tissue were gently grasped between 
the left thumb and forefingers.  
 Enough skin and adipose tissue was grasped to form a distinct fold 
that separates from the underlying muscle. The skinfold was grasped 2.0 
cm above the place, the measurement taken .The jaws of the calipers were 
placed at the marked level, perpendicular to the length of the fold, and the 
skinfold thickness was measured to the nearest 0.1 mm while the fingers 
continue to hold the skinfold. Skin fold measurements were taken at 6 
sites namely Triceps, Biceps, Thigh, Subscapular, Suprailiac and 
Abdomen. The measurements were divided into two groups Central fat 
Mass (CFM) and Peripheral fat mass (PFM). For the assessment of CFM 
the sum of Abdominal, Suprailiac and Subscapular were used and for the 
assessment of PFM the sum of Triceps, Biceps and Thigh were used. The 
ratio of CFM to PFM was analysed in both control and study group, sex 
wise (European Journal of Endocrinology, Volume 156, Issue 6, 655-
661). 
4. SERUM LIPID PROFILE 
 For venous blood specimen, participants were advised overnight 
fasting and blood sample drawn the other day morning and sent for 
analysis. Total cholesterol, HDL, Triglycerides were analysed from the 
serum blood samples and LDL was calculated using the following 
formula:- 
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  LDL = TC –TGL/5 – HDL.  
Consent     : Obtained  
Financial support    :  Nil 
Ethical committee clearance  :  Obtained   
Conflict of interest   : Nil 
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RESULTS 
 The results of clinical evaluation were shown below. In our study, 
the study population was divided into IHD and Non IHD groups. 
Statistical analysis was carried out in 98 patients after categorizing each 
variable. Age, BMI, Waist hip ratio, sum of central skin fold thickness, 
sum of peripheral skin fold thickness, LDL in analysed in IHD and non 
IHD patients.  
          Statistical analysis was carried out using standard formulae. 
Microsoft excel 2003 and SPSS (statistical package for social sciences) 
version 13.0 softwares were used for data entry and analysis.  
           BMI, Waist hip ratio, LDL were analysed using Chi – Square test. 
The significance of difference in mean in means for sum of central and 
peripheral skin folds thickness were calculated using t tests. Statistical 
significance is taken when P < 0.05. 
           Both the groups were matched for age, sex and risk factors other 
than the one studied, namely smoking, alcoholism, diabetes, 
hypertension, family H/o. There is no statistical difference is noted 
between the two groups in age, sex, smoking, alcoholism, Hypertension, 
Diabetes, Family H/o. In all these parameters compared between these 
groups the P value is more than 0.05 which is statistically insignificant. 
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TABLE 1 
AGE DISTRIBUTION 
 
Cases and Controls Age Group 
( in years) Number Percentage 
< 30 6 6.74 
31-40 14 14.28 
41-50 38 38.77 
51-60 40 40.81 
Total 98 100 
Mean 
Standard deviation 
47.54 yrs 
8.4yrs 
 
 
 
 The Mean age of patients in our study was 47.54±8.4yrs. Majority 
of patients were in the 4th to 5thdecade at the time of presentation. 
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TABLE 2 
 
SEX DISTRIBUTION 
                            
 Table 2 shows sex distribution of the study. Majority of the 
patients were males. Male to female ratio was 5:1 
 
 
TABLE 3 
RISK FACTORS 
 
RISK FACTOR CASES PERCENTAGE CONTROLS PERCENTAGE
SMOKING 32 65.3% 32 65.3% 
ALCOHOL 
INTAKE 
27 55.1% 27 55.1% 
DIABETES 10 20.4% 10 20.4% 
HYPERTENSION 11 22.4% 11 22.4% 
FAMILY H/O IHD 11 22.4% 11 22.4% 
NO RISK 
FACTORS 
8 16.32% 8 16.32% 
                                               
                                                  
 Table 3 shows the risk factors. Majority of the patients had atleast 
one risk factor. 8 of them had no risk factors.  
                                              
SEX CASES CONTROLS TOTAL PERCENTAGE 
MALE 41 41 82 83.7% 
FEMALE 8 8 16 16.3% 
TOTAL 49 49 98 100% 
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TABLE 4 
 
BODY MASS INDEX (BOTH MALE& FEMALE) 
 
GROUPS BMI NUMBER PERCENTAGE P VALUE
< 25 40 81.6% 0.13648 
CASES 
≥ 25 9 18.4%  
< 25 45 91.8%  
CONTROLS 
≥ 25 4 8.2%  
 
 
 Table 4 shows BMI. It is statistically insignificant and shows a 
weaker association between IHD and BMI. The mean of the BMI in 
Females were comparable (22.12 in Cases, 21.82 in Controls) with that of 
males (22.17 in Cases, 21.48 in Controls).                
 
TABLE 5 
 
WAIST HIP RATIO FOR MALES 
 
WAIST HIP 
RATIO 
CASES % CONTROLS % P VALUE 
NORMAL  
( ≤ 0.88) 
3 10.7% 25 89.3% 0.001 
ABNORMAL 
( > 0.88) 
38 70.4% 16 29.6%  
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TABLE 6 
WAIST HIP RATIO FOR FEMALES 
 
WAIST HIP 
RATIO CASES % CONTROLS % P VALUE 
NORMAL 
 ( ≤ 0.81) 0 0% 2 100% 0.13 
ABNORMAL 
( > 0.81) 8 57.1% 6 42.9%  
 
Table 5 & 6 shows waist hip ratio. For Males it was statistically 
significant, females it was statistically insignificant. 70.4% had abnormal 
ratio in cases than in controls (30%) in Males. In females 57.1% had 
abnormal ratio in cases than in controls (42.9%).Mean of WHR among 
males between the two groups were 0.97 (cases) and 0.87 (controls). 
Among the females the mean between the two groups were 0.96 (cases) 
and 0.87 (controls). 
TABLE 7 
WAIST CIRCUMFERENCE FOR MALES 
 
WAIST CASES % CONTROL % P VALUE 
NORMAL 
≤ 85 cm 19 38% 31 62% 0.006 
ABNORMAL 
> 85 cm 22 68.8% 10 31.3%  
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TABLE 8 
WAIST CIRCUMFERENCE FOR FEMALES 
 
WAIST CASES % CONTROL % 
P  
VALUE 
NORMAL  
≤ 80 cm 
3 37.5% 5 62.5% 0.31 
ABNORMAL 
> 80 cm 
5 62.5% 3 37.5%  
                    
 
 Table 7 & 8 shows the waist circumference. It was statistically 
significant in males, but statistically insignificant in females. Cases had 
higher waist circumference. The mean of WC among males between the 
two groups were 85.24 (cases) and 78.41 (controls). Among the females, 
between the two groups it was 85.52 (cases) and 78.39 (controls).    
 
                                              
TABLE 9 
RATIO OF CENTRAL TO PERIPHERAL 
SKIN FOLD THICKNESS FOR MALES 
 
RATIO NUMBER MEAN SD P VALUE 
CASES 41 1.3098 0.223 0.872 
CONTROLS 41 1.3098 0.234  
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TABLE 10 
RATIO OF CENTRAL TO PERIPHERAL 
SKIN FOLD THICKNESS FOR FEMALES 
 
RATIO NUMBER MEAN SD P VALUE 
CASES 8 1.1955 0.230 0.825 
CONTROLS 8 1.1749 0.121  
                                                  
 
 
TABLE 11 
CENTRAL AND PERIPHERAL SKIN FOLD 
THICKNESS IN MALES 
 
GROUP 
SUM OF CENTRAL 
SKIN FOLDS 
SUM OF PERIPHERAL 
SKIN FOLDS 
 MEAN SD MEAN SD 
CASES 4.81 1.14 3.71 0.9 
CONTROLS 3.47 1.06 2.68 0.71 
P VALUE 0.001 0.001 
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TABLE 12 
 
CENTRAL AND PERIPHERAL SKIN FOLD 
THICKNESS IN FEMALES 
 
GROUP 
SUM OF CENTRAL 
SKIN FOLD THICKNESS
SUM OF THE 
PERIPHERAL SKIN 
FOLD THICKNESS 
 MEAN SD MEAN SD 
CASES 6.21 1.5 5.37 1.72 
CONTROLS 4.65 1.52 4.05 5.37 
P VALUE 0.058 0.135 
 
 
                                               TABLE 13 
 
SUM OF ALL SKIN FOLD THICKNESS IN BOTH SEXES 
 
GROUP MALES FEMALES 
 MEAN SD MEAN SD 
CASES 8.52 1.91 11.58 3.11 
CONTROLS 6.15 1.69 8.7 3.1 
P VALUE 0.001 0.085 
 
 
 Table 9 to 13 shows the skin fold thickness between the two groups 
for males and females respectively.  
 The skin fold thicknesses were more in females than in males with 
the mean of sum of the central skin fold thickness in females (6.21) more 
than males (4.81) and the mean of sum of the peripheral thickness in 
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females (5.37) more than males (3.71). The skin fold thicknesses were 
more in cases than controls. The mean of the sum of central skin fold 
thickness was more in cases (4.81 in Males, 6.21 in Females) than in 
controls (3.47 in males, 4.65 in females). The mean of the sum of 
peripheral skin fold thickness was more in cases (3.71 in Males, 5.37 in 
females) than in controls (2.68 in Males, 4.05 in Females). 
           Central skin fold thickness was more than the peripheral skin fold 
thickness. The mean of the sum of CENTRAL SKIN FOLD 
THICKNESS was more in CASES (4.81 in males, 6.21 in Females) and 
in CONTROLS (3.47 in Males, 4.65in Females) than the mean of the sum 
of the PERIPHERAL SKIN FOLD THICKNESS in CASES (3.71 in 
Males, 5.37 in females) and in CONTROLS (2.68 in Males, 4.05 in 
Females).           
                                               TABLE 14 
 
                                     LDL FOR BOTH SEXES  
 
LDL CASES % CONTROLS % 
P 
VALUE 
< 130 
mg/dl 
16 28.1% 41 71.9% 0.00 
≥ 130 
mg/dl 
33 80.5% 8 19.5%  
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TABLE 16 
 
CORRELATION BETWEEN LDL, WAIST CIRCUMFERENCE, 
WH RATIO, BMI, SKIN FOLD THICKNESS FOR MALES 
 
  
  Table 16 shows correlation between the Waist hip ratio correlated 
well with   LDL in males which is statistically significant. Sum of skin 
fold thickness and Central skin fold thickness correlated with LDL with a 
statistical significance. But the ratio of central to peripheral skin folds did 
not correlate with LDL. 
 
TABLE 17 
 
CORRELATION BETWEEN LDL, WAIST CIRCUMFERENCE, 
WH RATIO, BMI, SKIN FOLD THICKNESS FOR FEMALES 
 
 
 BMI 
WH 
RATIO 
WC 
SUM OF 
ALL SKIN 
FOLDS 
CFM 
CFM TO 
PFM 
RATIO 
LDL 0.187 0.001 0.065 0.001 0.001 0.936 
 BMI 
WH 
RATIO 
WC 
SUM OF 
ALL SKIN 
FOLDS 
CFM 
CFM TO 
PFM 
RATIO 
LDL 0.739 0.268 0.080 0.019 0.014 0.958 
70 
 
Table 16 shows correlation between the Waist hip ratio did not 
correlate  with LDL in females. Sum of skin fold thickness and Central 
skin fold thickness correlated with LDL with a statistical significance. 
But the ratio of central to peripheral skin folds did not correlate with 
LDL.                     
TABLE 18 
 
CORRELATION BETWEEN WH RATIO 
AND SKIN FOLD THICKNESS 
 
                            
 
 
    
 
 Table 18 WH Ratio correlated with CFM in males but with poor 
correlation in females. 
 
                              
 CFM 
WH RATIO 
MALES - 0.001 
FEMALES – 0.70 
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DISCUSSION 
 In the western population numerous studies are being conducted on 
the association of obesity with cardiovascular risk.In India clinical 
regarding obesity and its role in Ischemic Heart disease are limited. This 
study is an attempt to emphasize the magnitude of the problem and to 
highlight the importance of early detection and treatment. 
COMPARABLE STUDIES 
1. INTERHEART STUDY, Lancet 2005; 366  
 A Standardized case control study was performed in 15152 cases 
of first myocardial infarction and 14820 age matched and sex matched 
controls. The main purpose of the study was to assess whether markers of 
obesity especially waist to hip ratio would be a stronger indicator of 
myocardial infarction than body mass index. 
           BMI was only slightly higher or there was no difference between 
the cases and controls. Cases had a higher waist to hip ratio than controls, 
an observation consistent in all the regions of the world. The risk of 
myocardial infarction rose progressively with increasing values for waist 
hip ratio.            
           Waist circumference was strongly related to myocardial infarction 
risk and this relation was continuous and persisted even after adjustment 
72 
 
for BMI and Height. Waist circumference was intermediate between BMI 
and waist hip ratio. 
           A trend towards lower risk of myocardial infarction was noted as 
hip circumference increased. This trend was highly significant after 
adjustment for BMI and height.  
          Of the two measures compared, BMI showed the weakest 
association with myocardial infarction risk in all ethnic groups with no 
significant relation in south Asians. 
OUR STUDY :  BMI showed weak association with Myocardial 
infarction. Waist hip ratio was strongly correlated with IHD overall (P 
value of 0.001). Cases had higher waist hip ratio than controls overall 
[70.4% of cases had abnormal WH ratio when compared to controls 
(29.6%)]. Waist circumference was strongly correlated with IHD overall 
(0.0040). 67.5% of the cases had abnormal waist circumferences than 
controls (32.5%). Waist circumference was in between waist hip ratio and 
BMI. All these go with our study also.   
2.  British journal of nutrition 2001 Vol 86: BMI does not 
accurately predict overweight in Asian Indians in northern India 
(AIIMS, NEW DELHI) 
           The main purpose of the study was to establish appropriate cut-off 
levels of the BMI for defining overweight, considering percentage BF in 
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healthy Asian Indians in northern India as the standard. A total of 123 
healthy volunteers (eighty-six males aged 18±75 years and thirty-seven 
females aged 20±69 years) participated in the study.  
           Two definitions of overweight were used. BMI >25 kg/m2 and BF 
>25 % in males and >30 % in females were used as twin criteria. A high 
waist hip ratio was defined as >0.95 in males and >0.80 in females. The 
sum of skinfold thickness was defined as high when the value exceeded 
50 mm. A high waist circumference was defined as 102 cm in males and 
88 cm in females.  
         The mean BMI of females was higher than that of males (P 
<0.029).The waist circumference was similar in males and females (P 
<0.367).  But the waist hip ratio was significantly higher in males (P 
<0.001): The sum of skinfold thickness was higher in females than in 
males (P <0.001). Similarly, peripheral and central skinfold thickness was 
higher in females (P <0.001 and P <0.048 respectively).  
OUR STUDY :  BMI of males and females were equal. Waist hip ratio 
was significant in males (P value 0.001) but not significant in females (P 
value 0.31). Waist hip ratio was higher in males than in females. Both 
Central and peripheral skin fold thickness were more in Females than in 
males. Sum of the skin fold thickness were more in females than males.  
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3. Relation of anthropometry to CVD risk factors in young obese 
women: Biomedical Research 2005; 16 (2): 137-141:- 
 The main objective of the study was to know the correlation of 
obesity as determined by anthropometry (height, weight, triceps skinfold 
thickness, hip and waist circumference) to altered blood lipid levels, 
glucose, fibrinogen and Blood Pressure (BP) in nulliparous women of 18-
26 years. It involved 50 women in the age group of 18-26 years of which, 
twenty five women with BMI ≥ 25 kg/m2 constituted the test group while 
twenty five women whose BMI was < 25kg/m2 were taken as controls. 
All the women selected were nulliparous, non-diabetic and healthy 
subjects.  
 A significant increase in BMI, waist circumference, hip 
circumference and skinfold thickness was observed in the obese group. 
However WHR was not found to be statistically significant. Significant 
increase in the both the Systolic Blood Pressure (SBP) and Diastolic 
Blood Pressure (DBP) was observed in the obese group. Most important 
finding was a significant decrease in HDL-C levels in the test group. 
Paradoxically TC was also found to be lesser in the test group. There was 
no statistically significant difference between the mean values of TG, 
LDC -C or Non HDL-C of the two groups.  
 A significant negative correlation of BMI with HDL–C and TG (r 
= -0.415; -0.402 respectively) was observed in the test group.    
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OUR STUDY : WH Ratio was statistically insignificant in Females 
which goes with this study.  
4. Journal of Clinical and Diagnostic Research. 2008Aug (2) 
Anthropometric Profile in Normolipidaemic Myocardial Infarction 
Patients in South Asia 
 The objective of the study was to evaluate the changes in 
anthropometric variables in Normolipidaemic acute myocardial infarction 
(AMI) patients, and to determine the significance of waist-hip ratio and 
basal metabolic index in assessment of risk of myocardial infarction as 
compared to normal healthy controls. A ratio of ≥ 0.85 for women and ≥ 
0.9 for men was considered for the prediction of risk.  
 Abdominal fat was found to be the strongest predictor of 
cardiovascular complications in subjects whose W/H ratio was in the top 
quartile (>0.98 for men and >0.091 for women). The estimated 
percentage rate of coronary heart disease (CHD, p<0.01) and death 
(p<0.01), myocardial infarction (p<0.01), stroke (p<0.01), and total CVD 
(p<0.01), increased with the increasing quartile of W/H ratio in both men 
and women. It was concluded that Asian Indians have a higher 
cardiovascular risk, even when BMI and WC values are within normal 
range, and suggested that the definitions of “normal” ranges of BMI and 
WC need to be revised for Asian Indians and Waist hip ratio is a useful 
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predictor of CVD than BMI. Waist-hip ratio is a useful predictor of CVD 
than BMI. 
OUR STUDY : Abdominal fat was found to be the strongest predictor of 
cardiovascular events with increased waist hip ratio in cases than in 
controls. 70.4% of cases had high waist hip ratio when compared to 
controls (30%) which also concludes that Indians have a higher risk of 
cardiovascular risk even when BMI, WH ratio was normal. 
5.  Indian J Med Res 117, April 2003, pp 170-179 - Receiver 
operating characteristics curve analysis of body fat & body mass 
index in dyslipidaemic Asian Indians:- 
 Optimal limit of body mass index (BMI) for Asian Indians remains 
to be defined. In this study, we describe the anthropometric and lipid 
profiles and determine the appropriate cut-offs of BMI for defining 
obesity in dyslipidaemic patients. Correlations were carried out between 
lipid profile and anthropometric variables in 217 dyslipidaemic Asian 
Indians and the data were compared to those of 123 healthy historical 
controls. Receiver operating characteristics (ROC) curve analysis was 
carried out to determine the appropriate cut-offs of BMI for defining 
obesity taking the percentage of body fat (% BF) as the standard.  
          Values of sigma 4 SF (P<0.001), and percentage of BF (P<0.001) 
were significantly higher in females. The central to peripheral skinfolds 
ratio were higher in men as compared to women (P<0.001). 
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         Significantly higher mean values of other variables in 
dyslipidaemic subjects were; WC (P<0.05 in both genders), sigma 4SF 
(P<0.05 in both genders), central skinfolds (P<0.05 in both genders), 
central to peripheral skinfolds ratio (P<0.05 in males and P=NS in 
females). 
OUR STUDY :  Ratio of the skin fold thickness were more in males than 
females ( Mean – 1.3058, Females 1.1852, P value 0.048 which was 
statistically significant at 5% level). The ratio of central to peripheral skin 
fold thickness was insignificant in both males and females and did not 
correlate with LDL which goes against the above study. LDL correlated 
with WH ratio in males but not in females. LDL also correlated with 
Central skin folds and the sum of all the skin folds in both the sexes. All 
these go with our study also. 
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CONCLUSIONS 
1.  The mean BMI of the south Indian males was 21.82 and that of 
south Indian females was 21.97.  
2.  BMI does not properly define obesity and the risk of 
cardiovascular events. BMI can be normal in a patient with 
cardiovascular disease. 
3. Abdominal obesity is an independent risk factor for coronary heart 
disease. Waist hip ratio and waist circumference are better 
indicators of the cardiovascular risk in a given individual than 
BMI. 
4. Waist hip ratio is a significant factor in males but not in females. 
5. The central skin fold thickness was significant in males but not in 
females. 
6.  For the same BMI, females had more uniform distribution of fat 
than males who had predominantly more distribution of fat in 
abdominal region. 
7. Central obesity leads to atherogenic lipid profile in both the sexes 
and places the individual at high risk of cardiovascular events.     
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PROFORMA 
Name:- 
Age:- 
Sex:- 
Address:- 
Occupation:- 
Smoker/ Not:- 
Alcoholic/ Not:- 
H/o Diabetes:- 
H/o HT:- 
Family H/o of IHD, Diabetes:- 
O/E: - Height:- 
          Weight:- 
          BMI:- 
Waist Circumference:- 
         Hip Circumference:- 
         Waist Hip Ratio:- 
         Skin Fold Thickness:- 
1)  Triceps:- 
2)  Biceps:- 
3)  Subscapular: 
4)  Supra-iliac:- 
5)  Abdomen:- 
6)  Thigh:- 
